Drug resistance and drug development in multiple myeloma
- 作者William S. Dalton
- 卷第29卷
- 印刷ISSN0093-7754
- 文件大小277.33KB
- 发表时间2002
- DOI10.1016/s0093-7754(02)70057-2
- 页码21-25
Etoposide (VP-16–213)O'Dwyer, Peter J.; Leyland-Jones, Brian; Alonso, M. Teresa; Marsoni, Silvia; Wittes, Robert E. · New England Journal of Medicine · 1985
Adjuvant Chemotherapy for Colon Cancer: Italian StudiesMarsoni, Silvia; Torri, Walter · Tumori Journal · 1997
NCI's clinical trials monitoring serviceSmith, Craig; Royds, Robert; Bono, Vincent; Marsoni, Silvia; Hoth, Daniel · Controlled Clinical Trials · 1982
Efficacy, semantic and chemotherapy in advanced NSCLCMarsoni, Silvia; Clerici, Maurizia · Annals of Oncology · 1994
Fluorouracil and folinic acid in colon cancerLuke Hughes-Davies; John Rescigno; Silvia Marsoni · 1995
A lesson from vorinostat in pleural mesotheliomaGarassino, Marina Chiara; Marsoni, Silvia · The Lancet Oncology · 2015
Spiromustine: a new agent entering clinical trialsD. Dale Shoemaker; Peter J. O'Dwyer; Silvia Marsoni; Jacqueline Plowman; J. Paul Davignon; Ruth D. Davis · 1983
Integrating liquid biopsies into the management of cancerSiravegna, Giulia; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto · Nature Reviews Clinical Oncology · 2017